[go: up one dir, main page]

PT1368016E - Formas de dosagem parenterica que compreendem uma suspensao de sal de tramadol e sal de diclofenac - Google Patents

Formas de dosagem parenterica que compreendem uma suspensao de sal de tramadol e sal de diclofenac

Info

Publication number
PT1368016E
PT1368016E PT01994735T PT01994735T PT1368016E PT 1368016 E PT1368016 E PT 1368016E PT 01994735 T PT01994735 T PT 01994735T PT 01994735 T PT01994735 T PT 01994735T PT 1368016 E PT1368016 E PT 1368016E
Authority
PT
Portugal
Prior art keywords
salt
suspension
parenteric
dosage
understand
Prior art date
Application number
PT01994735T
Other languages
English (en)
Inventor
Bartholomaeus Johannes
Heinrich Kugelmann
Original Assignee
Gruenenthal Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruenenthal Gmbh filed Critical Gruenenthal Gmbh
Publication of PT1368016E publication Critical patent/PT1368016E/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/192Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PT01994735T 2000-11-28 2001-11-27 Formas de dosagem parenterica que compreendem uma suspensao de sal de tramadol e sal de diclofenac PT1368016E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10059020A DE10059020A1 (de) 2000-11-28 2000-11-28 Parenteral applizierbare Darreichungsformen

Publications (1)

Publication Number Publication Date
PT1368016E true PT1368016E (pt) 2006-08-31

Family

ID=7664956

Family Applications (1)

Application Number Title Priority Date Filing Date
PT01994735T PT1368016E (pt) 2000-11-28 2001-11-27 Formas de dosagem parenterica que compreendem uma suspensao de sal de tramadol e sal de diclofenac

Country Status (12)

Country Link
US (1) US6875447B2 (pt)
EP (1) EP1368016B1 (pt)
JP (1) JP4188084B2 (pt)
CN (1) CN100384410C (pt)
AT (1) ATE323477T1 (pt)
AU (1) AU2002224896A1 (pt)
CY (1) CY1105625T1 (pt)
DE (2) DE10059020A1 (pt)
DK (1) DK1368016T3 (pt)
ES (1) ES2262703T3 (pt)
PT (1) PT1368016E (pt)
WO (1) WO2002043723A1 (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007023205A1 (en) * 2005-08-24 2007-03-01 Telechemistry Oy A method of testing a liquid sample, a test unit, and an automized system of a plurality of test units
WO2008093686A1 (ja) 2007-01-29 2008-08-07 Medrx Co., Ltd. 非ステロイド系抗炎症薬と有機アミン化合物との塩とその用途
AU2013204763B2 (en) * 2008-01-14 2015-06-04 Biokit, S.A. Device for distributing particles in a fluid and methods therefor
US8182762B2 (en) * 2008-01-14 2012-05-22 Biokit, S.A. Device for distributing particles in a fluid and methods thereof
EP2281558A1 (en) * 2009-08-06 2011-02-09 Laboratorios Del. Dr. Esteve, S.A. Pharmaceutical compounds of O-Desmethyl-Tramadol and COX-inhibitors
EP2593096A4 (en) * 2010-07-12 2014-02-26 Yung Shin Pharm Ind Co Ltd DICLOFENAC SALT OF TRAMADOL
US8895622B2 (en) 2011-04-12 2014-11-25 Revogenex Ireland Ltd. Intravenous administration of tramadol
US9980900B2 (en) 2015-12-22 2018-05-29 Revogenex Ireland Ltd Intravenous administration of tramadol
US9693949B1 (en) 2015-12-22 2017-07-04 Revogenex Ireland Ltd Intravenous administration of tramadol
US10022321B2 (en) 2016-06-30 2018-07-17 Revogenex Ireland Ltd. Intravenous administration of tramadol

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4016273A (en) * 1975-07-16 1977-04-05 American Cyanamid Company Sustained release forms of certain oxazepines for parenteral administration
DE3324193A1 (de) * 1983-07-05 1985-01-17 Troponwerke Gmbh & Co Kg Depot-antiphlogistika
US5283067A (en) * 1987-01-30 1994-02-01 Ciba-Geigy Corporation Parenteral suspensions
DK0566709T5 (da) * 1991-09-06 2009-05-18 Ortho Mcneil Janssen Pharm Præparat indeholdende et tramadolmateriale og acetaminophen og anvendelse deraf
AU661723B2 (en) * 1991-10-30 1995-08-03 Mcneilab, Inc. Composition comprising a tramadol material and a non-steroidal anti-inflammatory drug
US5594091A (en) * 1994-02-21 1997-01-14 Takeda Chemical Industries, Ltd. Matrix for sustained-release preparation
ATE223202T1 (de) * 1994-09-30 2002-09-15 Mika Pharma Ges Fuer Die Entwi Pharmazeutische zusammensetzung
AU7472798A (en) * 1997-05-07 1998-11-27 Algos Pharmaceutical Corporation Cox-2 inhibitors in combination with nmda-blockers for treating pain
DE19732928C2 (de) * 1997-07-31 2000-05-18 Gruenenthal Gmbh Verwendung substituierter Imidazolidin-2,4-dion-Verbindungen als Schmerzmittel
WO2000029022A1 (en) * 1998-11-12 2000-05-25 Algos Pharmaceutical Corporation Cox-2 inhibitors in combination with centrally acting analgesics
JP2002538078A (ja) * 1998-11-12 2002-11-12 アルゴス ファーマシューティカル コーポレーション 痛みを治療するnmda−ブロッカーと組み合わされたcox−2阻害剤
EP1180020B2 (en) * 1999-05-27 2009-06-24 Acusphere, Inc. Porous drug matrices and methods of manufacture thereof

Also Published As

Publication number Publication date
JP4188084B2 (ja) 2008-11-26
US20030203037A1 (en) 2003-10-30
DE10059020A1 (de) 2002-05-29
JP2004514692A (ja) 2004-05-20
CY1105625T1 (el) 2010-12-22
US6875447B2 (en) 2005-04-05
WO2002043723A1 (de) 2002-06-06
CN1477955A (zh) 2004-02-25
EP1368016A1 (de) 2003-12-10
ES2262703T3 (es) 2006-12-01
CN100384410C (zh) 2008-04-30
AU2002224896A1 (en) 2002-06-11
EP1368016B1 (de) 2006-04-19
ATE323477T1 (de) 2006-05-15
DE50109572D1 (de) 2006-05-24
DK1368016T3 (da) 2006-07-31
HK1060971A1 (en) 2004-09-03

Similar Documents

Publication Publication Date Title
UY27940A1 (es) Formulacion de anticuerpos humanos para el tratamiento de trastornos asociados con tnf-a
HN2002000030A (es) Nueva sal succinato de o-desmetil-venlafaxina
AR046970A1 (es) Esteres de fosfato de florfenicol
ATE514418T1 (de) Rasch zerfallende feste darreichungsformen mit nichtbröseliger konsistenz und pullulan
NO20054681L (no) Farmasoytiske produkter
ECSP024341A (es) Composiciones farmaceuticas
DK0840606T3 (da) Små di- og trivalente molekyler som selectininhibitorer
MXPA04002009A (es) Composicion farmaceutica que comprende gabapentina o un analogo de la misma y alfa-aminoamida y su uso como analgesico.
MA27115A1 (fr) Sel de perindopril et les compositions pharmaceutiques qui les contiennent
PT1368016E (pt) Formas de dosagem parenterica que compreendem uma suspensao de sal de tramadol e sal de diclofenac
ATE432068T1 (de) Cetirizin und pseudoephedrin enthaltende tablette
MX2007000117A (es) Una composicion de combinacion.
BRPI0410044B8 (pt) forma de dosagem contendo pantoprazol como ingrediente ativo
DK1353948T3 (da) Oplöselige biologiske analoge til bata-amyloidpeptid
HRP20031057B1 (hr) Tableta koja sadrži cetirizin i pseudoefedrin
IS6087A (is) N-(2-fenýl-4-amínó-bútýl)-1-naftamíð sem virka á móti taugakínín-1 viðtaka
EA200800698A1 (ru) Способ стабилизации фармацевтических форм для введения, включающих микроорганизмы
BRPI0417265A (pt) composição farmacêutica compreendendo um princìpio ativo e sulfobetaìna
EA200300639A1 (ru) Применение sarp-1 для лечения и/или предупреждения склеродермии
AR042037A1 (es) Profarmaco de celecoxib
GT200400183A (es) Formas de dosificacion de azitromicina con efectos secundarios reducidos
SE0203817D0 (sv) New composition
ATE402703T1 (de) Tablette enthaltend efletirizin und pseudoephedrin
BRPI0414423A (pt) inibidores de pace4, suas composições farmacêuticas e respectivos usos
GEP20084546B (en) Novel association consisting of an anti-atherothrombotic agent and of platelet antiaggregating agent